Search

Research

Group A Streptococcus (GAS) is a major human pathogen responsible for superficial infections through to life-threatening invasive disease and the autoimmune sequelae acute rheumatic fever (ARF). Despite a significant global economic and health burden, there is no licensed vaccine available to prevent GAS disease. Several pre-clinical vaccines that target conserved GAS antigens are in development.

Research

Public health systems face tensions between individuals and the collective. Parents who selectively vaccinate demonstrate this tension

News & Events

Are you pregnant or planning to have a baby? There are important vaccinations that you should consider to protect your health and the health of your baby.

News & Events

As a new parent or parent-to-be, you will be faced with many important decisions about your health and the health of your child, including immunisation.

News & Events

You are invited to register to attend the National Indigenous Immunisation Research Workshop 2013: lessons learnt and future directions Workshop.

News & Events

Common myths about immunisation have been laid to rest in a new booklet written by top immunologists and published by the Australian Academy of Science.

Research

Although influenza vaccination is recommended during pregnancy as standard of care, limited surveillance data are available for monitoring uptake.

Research

Group A Streptococcus (GAS) M protein is an important virulence factor and potential vaccine antigen, and constitutes the basis for strain typing (emm-typing).

Research

Vaccine prevention of GAS infections and their immunological complications has been a goal of researchers for decades.

Research

The desire for an effective vaccine arises from the large burden of disease caused by the bacterium, particularly rheumatic fever and rheumatic heart disease.